Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 8333
118th Congress(2023-2024)
BIOSECURE Act
Active
Active
Passed House on Sep 9, 2024
Overview
Text
Introduced
May 10, 2024
Latest Action
Sep 10, 2024
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
8333
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Brad Wenstrup
Ohio
Democrat
Anna Eshoo
California
Republican
Neal Dunn
Florida
Republican
Darin LaHood
Illinois
Democrat
Raja Krishnamoorthi
Illinois
Republican
Ashley Hinson
Iowa
Democrat
Seth Moulton
Massachusetts
Democrat
Elissa Slotkin
Michigan
Republican
John Moolenaar
Michigan
Democrat
Josh Gottheimer
New Jersey
Republican
Elise Stefanik
New York
Democrat
Tom Suozzi
New York
Democrat
Donald G. Davis
North Carolina
Republican
Stephanie Bice
Oklahoma
Republican
Mark Green
Tennessee
House Votes (1)
Senate Votes (0)
checkPassed on September 9, 2024
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
402
House Roll Call Votes
Summary

BIOSECURE Act

This bill prohibits entities that receive federal funds from using biotechnology that is from a company associated with a foreign adversary.

Specifically, federal agencies and recipients of federal funds (e.g., grantees) may not procure or use any biotechnology equipment or service that is from a biotechnology company of concern and may not contract with any entities that do so. A biotechnology company of concern is an entity that is under the control of a foreign adversary and that poses a risk to national security based on its research or multiomic data collection (e.g., collection of genomic information).

The Office of Management and Budget (OMB) must, in coordination with the Department of Defense (DOD) and other specified agencies, develop a list of prohibited companies; the list must include five particular companies, as specified in the bill. OMB and DOD may approve waivers of these restrictions on an as-needed basis, which are valid for up to one year and may be extended once for an additional 180 days.

In addition, the Office of the Director of National Intelligence must report on the national security risks posed by (1) multiomic data collection by foreign adversaries in connection with biotechnology equipment or services, and (2) biotechnology companies that have such data.

Text (3)
Referred in Senate
September 10, 2024
Engrossed in House
September 9, 2024
Introduced in House
May 10, 2024
Actions (13)
09/10/2024
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
09/09/2024
Motion to reconsider laid on the table Agreed to without objection.
09/09/2024
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)
09/09/2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)
09/09/2024
Considered as unfinished business. (consideration: CR H5081-5082)
09/09/2024
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
09/09/2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 8333.
09/09/2024
Considered under suspension of the rules. (consideration: CR H5051-5058)
09/09/2024
Mr. Comer moved to suspend the rules and pass the bill, as amended.
05/15/2024
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 1.
05/15/2024
Committee Consideration and Mark-up Session Held
05/10/2024
Referred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/10/2024
Introduced in House
Public Record
Record Updated
Sep 13, 2024 11:38:14 PM
Copyright © 2024 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About